Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (151-160 of 290) with videos related to

Pageof 29
Sort By:
Neurology|October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencyV Worthington, J Killestein, M J Eikelenboom, et al.
Journal of Neurology|May 20, 2008
The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosisT A M Siepman, A C J W Janssens, I de Koning, et al.
European Radiology|May 24, 2000
Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosisJ C Bot, F Barkhof, G J Lycklama à Nijeholt, et al.
Neurology|July 28, 2004
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MSS C J Huijbregts, N F Kalkers, L M J de Sonneville, et al.
Psychoneuroendocrinology|January 1, 1994
Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitisC D Dijkstra, E R van der Voort, C J De Groot, et al.
Neuroimage. Clinical|November 2, 2013
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space studyM L Van der Meer, P Tewarie, M M Schoonheim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2013
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosisC van de Kraats, J Killestein, V Popescu, et al.
Annals of Neurology|October 1, 1990
4-Aminopyridine in multiple sclerosisC H Polman, H A van Diemen, M M van Dongen, et al.
Neurology|February 20, 1999
Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MSH M Schrijver, J B Crusius, B M Uitdehaag, et al.
Neurology|April 4, 2000
MS functional composite: relation to disease phenotype and disability strataN F Kalkers, V de Groot, R H Lazeron, et al.
Pageof 29

Showing results (151-160 of 290) with videos related to

Sort By:
Pageof 29
Neurology|October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencyV Worthington, J Killestein, M J Eikelenboom, et al.
Journal of Neurology|May 20, 2008
The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosisT A M Siepman, A C J W Janssens, I de Koning, et al.
European Radiology|May 24, 2000
Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosisJ C Bot, F Barkhof, G J Lycklama à Nijeholt, et al.
Neurology|July 28, 2004
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MSS C J Huijbregts, N F Kalkers, L M J de Sonneville, et al.
Psychoneuroendocrinology|January 1, 1994
Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitisC D Dijkstra, E R van der Voort, C J De Groot, et al.
Neuroimage. Clinical|November 2, 2013
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space studyM L Van der Meer, P Tewarie, M M Schoonheim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2013
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosisC van de Kraats, J Killestein, V Popescu, et al.
Annals of Neurology|October 1, 1990
4-Aminopyridine in multiple sclerosisC H Polman, H A van Diemen, M M van Dongen, et al.
Neurology|February 20, 1999
Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MSH M Schrijver, J B Crusius, B M Uitdehaag, et al.
Neurology|April 4, 2000
MS functional composite: relation to disease phenotype and disability strataN F Kalkers, V de Groot, R H Lazeron, et al.
Pageof 29